Earnings
NAVB
1.640
-1.80%
-0.030
Currencies: USD
Items
Total Revenue
Revenue
Cost of Revenue
Gross Profit
Marketing and Administrative Expenses
Research and Development Costs
Financial Expenses
Depreciation and Amortization
Other Expenses
Total Operating Expenses
Asset Impairments
Operating Income
Interest Income
Assets Disposal
Other Non-operating Net Income
Non-operating Income
Net Income Before Taxes
Provision for Income Taxes
Net Income
Minority Interests
Net Income Attributable to Shareholders
Net Income Attributable to Common Equities
Net Income from Discontinued Operations
Basic EPS
Diluted EPS
FY 2020-12-31
915.01K
915.01K
1050.00
913.96K
6.62M
4.93M
--
--
--
11.63M
--
-10.71M
11.34K
--
-21.85K
--
-10.72M
0.00
-10.72M
0.00
-10.72M
-11.39M
0.00
--
-0.48
FY 2019-12-31
657.83K
657.83K
6670.00
651.16K
6.13M
5.34M
--
--
--
11.62M
--
-10.96M
25.29K
--
-7610.00
--
-10.94M
710.00
-10.95M
20.00
-10.95M
-10.95M
-2670.00
--
-0.76
FY 2018-12-31
1.17M
1.17M
96.64K
1.07M
7.55M
4.22M
--
--
--
17.31M
--
-16.14M
-30.80K
--
1150.00
--
-16.17M
-9750.00
-16.16M
380.00
-16.16M
-16.16M
44.50K
--
-1.90
FY 2017-12-31
1.81M
1.81M
3650.00
1.81M
10.93M
4.51M
--
--
--
19.89M
--
-18.08M
322.33K
--
-33.34K
--
-17.79M
-4.06M
-13.73M
210.00
-13.73M
-13.73M
88.67M
--
-1.70
FY 2016-12-31
4.97M
4.97M
62.26K
4.91M
7.52M
7.14M
--
--
--
15.12M
--
-10.15M
2.80M
--
-27.92K
--
-7.38M
0.00
-7.38M
650.00
-7.38M
-7.38M
-6.93M
--
-0.95

FY: Financial Year. It represents annual report.

Q: Quarter Report. Q1、Q2、Q3、Q4 represent three-month periodic financial reports.

Check out NAVB latest quarterly and annual financial reports. There are also past financial reports for you to reference. You can analyze NAVIDEA BIOPHARM recent business situations from balance sheets, income statements, cash flow statements and other tables. This information may help you make smarter investment decisions.